1115118
GMP Laboratories of America Inc — FEI 3002710875
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Anaheim, CA (United States)
Citations
| ID | CFR | Description |
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 1361 | 21 CFR 211.100(a) | Absence of Written Procedures |
| 1418 | 21 CFR 211.42(c)(7) | Quarantined Drug Products Area |
| 2399 | 21 CFR 211.194(a)(2) | Laboratory Test Method Verification |
| 3445 | 21 CFR 211.65(a) | Equipment construction - reactive surfaces |